Skip to content

    Jazz Pharmaceuticals (JAZZ) stock price & financials

    View JAZZ earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+96.5% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $1.05B
    $1.09B
    $897.80M
    $1.05B
    $1.13B
    +6.7%
    $1.20B
    +10.1%
    $1.07B
    +19.1%
    $1.21B
    +15.5%
    Strengthening
    Operating Profit
    $260.21M
    $190.77M
    -$55.90M
    -$686.40M
    $57.51M
    -77.9%
    $254.55M
    +33.4%
    $336.60M
    $248.20M
    Strengthening
    Net Profit
    $215.06M
    $191.12M
    -$92.50M
    -$718.50M
    $251.41M
    +16.9%
    $203.44M
    +6.4%
    $293.10M
    $192.80M
    Strengthening
    EPS
    $3.50
    $-1.52
    $-11.74
    $4.14
    +18.3%
    $4.73
    $3.05
    Weakening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    $200.81M
    $133.22M
    -$109.80M
    -$735.60M
    $9.04M
    -95.5%
    $208.51M
    +56.5%
    $299.20M
    $211.00M
    Strengthening
    MarginsOPM
    24.7%
    17.5%
    -6.2%
    -65.6%
    5.1%
    -79.3%
    21.3%
    +21.2%
    31.5%
    20.5%
    Strengthening
    Tax
    -7.2%
    -43.5%
    16.2%
    2.3%
    -2683.2%
    -36960.4%
    2.4%
    2.0%
    -87.4%
    8.6%
    +266.7%
    Strengthening
    ReturnsROIC
    19.0%
    16.9%
    -8.2%
    -63.5%
    22.2%
    +16.9%
    18.0%
    +6.4%
    25.9%
    17.0%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$309.62M$637.34M$1.06B$591.45M$881.48M$1.51B$2.41B$1.39B$1.62B
    Short-Term Investments
    Total Current Assets$1.23B$1.63B$2.84B$2.61B$2.61B$3.44B$4.63B$4.17B$3.97B
    Net PP&E$200.36M$270.89M$257.10M$343.42M$301.38M$234.99M$227.00M$258.80M$264.10M
    Goodwill$927.63M$920.02M$958.30M$1.83B$1.69B$1.75B$1.72B$1.83B$1.80B
    Intangibles$2.73B$2.44B$2.20B$7.15B$5.79B$5.42B$4.76B$4.43B$4.03B
    Total Assets$5.20B$5.54B$6.54B$12.30B$10.84B$11.39B$12.01B$11.66B$11.08B
    LiabilitiesTotal Current Liabilities$345.49M$364.49M$653.75M$809.30M$933.19M$1.54B$1.04B$2.24B$2.23B
    Short-Term Debt$33.39M$33.39M$246.32M$31.00M$31.00M$604.95M$31.00M$1.03B$1.02B
    Long-Term Debt$1.56B$1.57B$1.85B$6.02B$5.69B$5.11B$6.08B$4.33B$3.33B
    Long-Term Leases$0$151.23M$140.03M$87.20M$71.84M$59.23M$38.94M$50.90M$43.60M
    Total Liabilities$2.45B$2.43B$2.88B$8.33B$7.75B$7.66B$7.92B$7.34B$6.28B
    EquityCommon Stock & APIC$6.0K$6.0K$6.0K$6.0K$6.0K$6.0K$6.0K$0$0
    Retained Earnings$841.05M$1.07B$1.16B$830.23M$733.59M$878.66M$1.13B$646.10M$1.13B
    Total Equity$2.76B$3.11B$3.66B$3.97B$3.09B$3.74B$4.09B$4.32B$4.80B
    HighlightsNet Cash / (Debt)-$1.29B-$969.91M-$1.04B-$5.46B-$4.84B-$4.21B-$3.70B-$3.97B-$2.73B

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$798.90M$776.40M$899.65M$778.51M$1.27B$1.09B$1.40B$1.36B$1.66B
    Cash from Investing-$394.49M-$155.30M-$1.01B-$5.21B-$446.23M-$163.06M-$508.19M-$1.51B-$221.91M
    Cash from Financing-$479.13M-$293.75M$528.07M$3.97B-$529.49M-$305.25M$20.52M-$873.38M-$1.01B
    SummaryCapital Expenditure-$20.37M-$40.13M-$15.00M-$27.64M-$29.05M-$23.96M-$38.07M-$58.75M-$69.75M
    Free Cash Flow$778.53M$736.27M$884.64M$750.87M$1.24B$1.07B$1.36B$1.30B$1.59B
    FCF Margin41.2%34.1%37.4%24.3%34.0%27.9%33.4%30.4%34.6%

    Ratios